XERS
Xeris Pharmaceuticals Inc
9.10$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +52.6% | +80.8% | +236.9% | +36.1% | +28.1% | +574.2% | +3.9% | -4.1% | -3.7% | |
| – | -7.6% | +246.3% | +275.2% | +27.6% | +37.6% | +6.8% | -11.9% | +71.4% | +21.8% | |
| – | +0.7% | +191.4% | +275.2% | +27.6% | +51.0% | +1.6% | – | – | – | |
| – | – | +43.4% | +632.9% | -123.8% | – | -396.5% | – | – | – | |
| – | +1,900.0% | +115.7% | -26.7% | -65.9% | +187.8% | -51.7% | +331.9% | -61.6% | -19.8% | |
| – | +1,900.0% | +9,651.6% | -96.5% | +1,050.0% | – | -64.8% | -117.4% | – | -114.3% | |
| – | – | – | – | +57.6% | -73.8% | +486.1% | – | – | – | |
| – | +796.6% | +179.8% | -104.5% | -98.6% | +747.6% | -12.4% | +115.6% | +270.1% | +191.3% | |
| – | – | +0.0% | +71.4% | +58.1% | +8.3% | +0.0% | -100.0% | – | -100.0% | |
| – | +800.1% | +264.9% | -37.2% | +56.5% | -78.4% | +367.8% | -101.3% | – | -68.5% | |
| – | – | -62.4% | -813.6% | – | +64.1% | +99.0% | -192.5% | – | +866.1% | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.